These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-003068-47 Behandling med botulinumtoxin vid neurogen blåsfunktionsstörning not-yet-due
Ongoing 2006-004892-36 An open randomized and comparative study on the efficacy and safety of additional treatment of subcutaneous immunoglobulin (Subcuvia) during cessation of Prednisolon in patients with active systemic l... not-yet-due
Ongoing 2009-012437-30 Clofarabine based remission induction followed by haploidentical stem cell transplantation in children with refractory hematological malignancies not-yet-due
Not reported 2010-019815-40 Avastin and chemotherapy followed by a KRAS stratified randomization to maintenance treatment for first line treatment of metastatic colorectal cancer 2014-05-07 due-trials
Ongoing 2011-000240-16 A MULTICENTER PHASE II STUDY EVALUATING EFFICACY AND SAFETY OF 177Lu-DOTA-TATE BASED ON KIDNEY-DOSIMETRY IN PATIENTS WITH DISSEMINATED NEUROENDOCRINE TUMORS not-yet-due
Not reported 2011-001452-11 Supplemental Oxygen in Catherized Coronary Emergency Reperfusion 2016-02-15 due-trials
Ongoing 2011-001520-37 Ketamine as an alternative to electroconvulsive therapy for treatment of major depressive disorder not-yet-due
Not reported 2011-001673-70 EPO to protect renal function after cardiac surgery. EPRICS. A phase II double blind randomized controlled study. 2013-01-03 due-trials
Ongoing 2011-004266-15 Androgen replacement in young hypogonadal men: a 2 year randomized, double-blind placebo controlled study not-yet-due
Ongoing 2011-006195-39 An open-label study to compare the prognostic value of (18F)Flutemetamol PET-imaging with longitudinal biomarker data in healthy volunteers and patients with mild cognitive impairment not-yet-due
Ongoing 2012-001879-37 A randomized multicenter phase III study of cisplatin plus radiotherapy compared to cetuximab plus radiotherapy in locally advanced head and neck cancer not-yet-due
Other 2012-003032-22 Allogenic stem cell transplantation in children and adolescents with acute lymphoblastic leukaemia not-yet-due
Ongoing 2012-004313-13 A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors. not-yet-due
Completed, but no date Terminated 2013-004176-35 A randomized, double blind, placebo-controlled, proof-of-concept study of FP187 in patients with mild to moderate Psoriatic Arthritis bad-data
Not reported 2013-004446-42 THE IMPORTANCE OF ALBUMIN INFUSION RATE FOR 2017-09-12 due-trials
Ongoing 2014-000422-38 An open-label study evaluating the diagnostic accuracy of [18F]-AV-1451 PET to detect and distinguish neurodegenerative disorders characterized by cerebral accumulation of tau not-yet-due
Ongoing 2014-002362-74 Palliative short-course hypofractionated radiotherapy followed by chemotherapy in adenocarcinoma of the esophagus or esophogastric junction trial - a phase II clinical trial protocol. not-yet-due
Reported results 2014-004610-29 Ciclosporin to Protect Renal function In Cardiac Surgery. CiPRICS. A Phase II Double Blind Randomized Placebo Controlled Study. 2016-09-23 due-trials
Exempt 2015-002470-20 Fentanyl and Clonidine for analgesia during hypothermia in term asphyxiated infants – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study. Cohort 1 in The SANNI project... not-yet-due
Ongoing 2015-004425-13 Prospective evaluation of 68-Ga-PSMA-PET and early PSA kinetics during salvage radiotherapy for personalizing the management of men with relapse of prostate cancer after radical prostatectomy. not-yet-due
Ongoing 2016-000494-20 A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Based Treatment with Focus on Mechanisms of Resistance to Endocrine Based Treatment (aromatase inhibitor ... not-yet-due
Ongoing 2017-000094-36 The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders not-yet-due
Ongoing 2017-005091-26 Clonidine for analgesia to preterm infants during neonatal intensive care – a prospective pharmacokinetic/pharmacodynamic/pharmacogenetic observational study. Cohort 2 in The SANNI project. not-yet-due
Ongoing 2018-000050-22 Irinotecan-based triplet (FOLFOXIRI) as perioperative treatment in resectable gastric and gastroesophageal junction adenocarcinoma. not-yet-due
Ongoing 2018-001846-32 Treatment of NF1-related plexiform neurofibroma with trametinib; a single arm, open-label trial with the goals of volumetric partial remission and pain relief not-yet-due